AZD4573
short engagement, selective CDK9 kinase inh. IV treatment in Ph. I for RR-heme cancers shortened t1/2 from prior preclin. candidate J. Med. Chem., Dec. 11, 2020 AstraZeneca, Cambridge, UK / Boston, MA
Molecules of the Month - December 2020
Molecules of the Month
- OI338
- PF07059013
- AZD0364
- PF-06843195
- TP0586352
- AZD4573
- "compound 42"
- "compound 12"
- BMS-986202
- pamiparib
- linrodostat
- SAR439859
- ACT-1004-1239
- "compound 1"